NEW YORK, July 17 (Reuters) - Bristol-Myers Squibb Co. and Japan's Otsuka Pharmaceutical Co. said on Tuesday that U.S. health regulators have granted a priority review for their schizophrenia drug ...

U.S. physicians indicate an almost 50-50 split when asked whether trackable pills will improve patient outcomes, according to a recent survey by SERMO, a global social network for physicians. The ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Abilify Asimtufii? Abilify Asimtufii contains the ...